{"id":"NCT00535288","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)","officialTitle":"A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Four Different Doses of Org 50081 in the Treatment of Moderate to Severe Vasomotor Symptoms Associated With the Menopause","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-09-15","primaryCompletion":"2006-01-15","completion":"2006-01-15","firstPosted":"2007-09-26","resultsPosted":"2014-07-30","lastUpdate":"2019-04-02"},"enrollment":946,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Postmenopausal Symptoms","Menopause","Vasomotor Symptoms"],"interventions":[{"type":"DRUG","name":"Esmirtazapine","otherNames":["Esmirtazapine maleate","SCH 900265","Org 50081"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Esmirtazapine 2.25 mg","type":"EXPERIMENTAL"},{"label":"Esmirtazapine 4.5 mg","type":"EXPERIMENTAL"},{"label":"Esmirtazapine 9 mg","type":"EXPERIMENTAL"},{"label":"Esmirtazapine 18 mg","type":"EXPERIMENTAL"}],"summary":"To investigate efficacy and safety of 4 doses of esmirtazapine, compared to placebo, in the treatment of moderate to severe hot flushes (vasomotor symptoms) associated with the menopause. Co-primary efficacy endpoints are the frequency and severity of hot flushes after 4 and 12 weeks as compared to Baseline.","primaryOutcome":{"measure":"Change From Baseline in Average Daily Frequency of Moderate/Severe Vasomotor Symptoms (Frequency Score A) at Week 4","timeFrame":"Baseline and Week 4","effectByArm":[{"arm":"Placebo","deltaMin":12.1,"sd":5.1},{"arm":"Esmirtazapine 2.25 mg","deltaMin":12.2,"sd":5.1},{"arm":"Esmirtazapine 4.5 mg","deltaMin":12.6,"sd":4.7},{"arm":"Esmirtazapine 9 mg","deltaMin":12.3,"sd":4.4},{"arm":"Esmirtazapine 18 mg","deltaMin":11.5,"sd":4.7}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.01"},{"comp":"OG000 vs OG002","p":"<0.01"},{"comp":"OG000 vs OG003","p":"<0.01"},{"comp":"OG000 vs OG004","p":"<0.01"}]},"eligibility":{"minAge":"40 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":16},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["30712391"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":314},"commonTop":["Fatigue","Somnolence","Headache","Weight increased","Increased appetite"]}}